179 related articles for article (PubMed ID: 12084340)
1. Cryosurgery for prostate cancer: new technology and indications.
Benoit RM; Cohen JK; Miller RJ
Curr Urol Rep; 2000 May; 1(1):41-7. PubMed ID: 12084340
[TBL] [Abstract][Full Text] [Related]
2. Counseling patients about cryotherapy for prostate cancer in the information age.
Benoit RM; Cohen JK; Miller RJ
Semin Urol Oncol; 2000 Aug; 18(3):226-32. PubMed ID: 10975495
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for cryoablation of the prostate in the management of localized prostate carcinoma?
Long JP
Hematol Oncol Clin North Am; 1996 Jun; 10(3):675-90. PubMed ID: 8773504
[TBL] [Abstract][Full Text] [Related]
4. Cryosurgery for prostate cancer.
Fahmy WE; Bissada NK
Arch Androl; 2003; 49(5):397-407. PubMed ID: 12893518
[TBL] [Abstract][Full Text] [Related]
5. Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation.
Burton S; Brown DM; Colonias A; Cohen J; Miller R; Rooker G; Benoit R; Merlotti L; Quinn A; Kalnicki S
Urology; 2000 Nov; 56(5):833-8. PubMed ID: 11068312
[TBL] [Abstract][Full Text] [Related]
6. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the hospital costs for radical prostatectomy and cryosurgical ablation of the prostate.
Benoit RM; Cohen JK; Miller RJ
Urology; 1998 Nov; 52(5):820-4. PubMed ID: 9801106
[TBL] [Abstract][Full Text] [Related]
8. Current status of minimally invasive treatment options for localized prostate carcinoma.
Beerlage HP; Thüroff S; Madersbacher S; Zlotta AR; Aus G; de Reijke TM; de la Rosette JJ
Eur Urol; 2000 Jan; 37(1):2-13. PubMed ID: 10671777
[TBL] [Abstract][Full Text] [Related]
9. Focal cryosurgical ablation of the prostate: a single institute's perspective.
Hale Z; Miyake M; Palacios DA; Rosser CJ
BMC Urol; 2013 Jan; 13():2. PubMed ID: 23311921
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma.
Miller RJ; Cohen JK; Shuman B; Merlotti LA
Cancer; 1996 Apr; 77(8):1510-4. PubMed ID: 8608536
[TBL] [Abstract][Full Text] [Related]
11. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results.
Cohen JK; Miller RJ; Rooker GM; Shuman BA
Urology; 1996 Mar; 47(3):395-401. PubMed ID: 8633408
[TBL] [Abstract][Full Text] [Related]
12. The biochemical efficacy of primary cryoablation combined with prolonged total androgen suppression compared with radiotherapy on high-risk prostate cancer: a 3-year pilot study.
Ko YH; Kang SH; Park YJ; Park HS; Moon du G; Lee JG; Yoon DK; Kim JJ; Cheon J
Asian J Androl; 2010 Nov; 12(6):827-34. PubMed ID: 20711215
[TBL] [Abstract][Full Text] [Related]
13. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate.
Long JP; Bahn D; Lee F; Shinohara K; Chinn DO; Macaluso JN
Urology; 2001 Mar; 57(3):518-23. PubMed ID: 11248631
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate.
Miller RJ; Cohen JK; Merlotti LA
Urology; 1994 Aug; 44(2):170-4. PubMed ID: 8048190
[TBL] [Abstract][Full Text] [Related]
15. [Cryosurgery in the management of prostate cancer].
Pontones Moreno JL; Morera Martínez JF; Vera Donoso CD; Jiménez Cruz JF
Actas Urol Esp; 2007 Mar; 31(3):211-32. PubMed ID: 17658150
[TBL] [Abstract][Full Text] [Related]
16. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
17. Histological findings in the prostate two years following cryosurgical ablation.
Donnelly BJ; Saliken JC; Ali-Ridha N; Rewcastle JC; White LJ
Can J Urol; 2001 Apr; 8(2):1237-9. PubMed ID: 11375788
[TBL] [Abstract][Full Text] [Related]
18. Erectile dysfunction following minimally invasive treatments for prostate cancer.
Chaikin DC; Broderick GA; Malloy TR; Malkowicz SB; Whittington R; Wein AJ
Urology; 1996 Jul; 48(1):100-4. PubMed ID: 8693628
[TBL] [Abstract][Full Text] [Related]
19. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
[TBL] [Abstract][Full Text] [Related]
20. [Cryosurgical ablation as primary treatment in prostate cancer patients].
Bjerklund Johansen TE
Actas Urol Esp; 2007 Jun; 31(6):651-9. PubMed ID: 17896562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
